Halcyon Health has secured $100,000 in funding from investors, marking a significant milestone for the technology and services platform. The company is dedicated to assisting patients with substance use through the full continuum of care. This investment round provides capital to further its mission of addressing critical gaps in the healthcare system.
The platform aims to tackle the challenge that less than four million of the 23 million people with Substance Use Disorder receive any care, with only a fraction accessing evidence-based treatment. Halcyon Health focuses on integrating coordinated care, medication-assisted treatment (MAT), peer recovery coaching, and social determinants, all of which are proven to correlate with better patient outcomes. This funding will enable the company to strengthen its operational capabilities and expand its reach.
Halcyon Health plans to use the newly raised capital for growth initiatives, including further development of its proprietary technology platform and the expansion of its service offerings. The investment underscores confidence in the company's approach to improving access to effective substance use care. By enhancing its infrastructure, Halcyon Health intends to scale its operations and serve a greater number of individuals in need.
This funding round is crucial for Halcyon Health as it continues to build out its comprehensive support system. The company is focused on increasing the availability of evidence-based care and improving recovery pathways for patients. Looking ahead, Halcyon Health is poised to expand its impact, striving to make a meaningful difference in the lives of those affected by substance use disorder through continued growth and innovation.
